A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511110-21-00

Acronym

BP45361

Enrollment

140

Registered

2024-08-27

Start date

2024-09-09

Completion date

Unknown

Last updated

2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson’s Disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026